Pfizer

#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
BioSpace
Fri, 05/30/25 - 11:49 am
ASCO 2025
chicago
Pfizer
Astellas
Evopoint Biosciences
Summit Therapeutics
Merck
ASCO: Pfizer, chasing full approval conversion for Braftovi combo, touts 'unprecedented' survival win
Fierce Pharma
Fri, 05/30/25 - 11:25 am
ASCO 2025
Pfizer
Braftovi
clinical trials
metastatic colorectal cancer
Pfizer and Arvinas gamble to shift breast cancer treatment paradigm
Clinical Trials Arena
Thu, 05/29/25 - 10:38 pm
Pfizer
Arvinas
breast cancer
vepdegestrant
Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial
Clinical Trials Arena
Fri, 05/23/25 - 08:31 am
Astellas
Pfizer
clinical trials
Xtandi
metastatic hormone-sensitive prostate cancer
prostate cancer
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Fierce Pharma
Thu, 05/22/25 - 11:27 am
Pfizer
FDA
adcomm
Talzenna
prostate cancer
FDA expands warnings of heart risks on COVID shots
Axios
Wed, 05/21/25 - 10:39 pm
Pfizer
Moderna Therapeutics
FDA
vaccines
myocarditis
COVID-19
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine
BioSpace
Wed, 05/21/25 - 12:00 pm
SK Bioscience
Pfizer
patents
legal
vaccines
pneumococcal disease
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
Yahoo/Reuters
Mon, 05/19/25 - 10:33 pm
Pfizer
China
3SBio
cancer
oncology
non-small cell lung cancer
metastatic colorectal cancer
Pfizer-backed CellCentric secures $120M for further myeloma trials
Fierce Biotech
Mon, 05/19/25 - 11:17 am
CellCentric
Pfizer
funding
Multiple Myeloma
clinical trials
inobrodib
Weighing approval bids from J&J, Pfizer and Roche, FDA scrutinizes data ahead of adcomm
Fierce Pharma
Sun, 05/18/25 - 10:33 pm
FDA
JNJ
Pfizer
Roche
cancer
accomm
Pfizer partner RemeGen says HER2 ADC prolongs life in newly diagnosed bladder cancer
Fierce Pharma
Mon, 05/12/25 - 11:36 am
RemeGen
Pfizer
antibody-drug conjugates
clinical trials
bladder cancer
In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen
Fierce Pharma
Thu, 05/8/25 - 10:56 pm
FDA
Richard Pazdur
Marty Makary
cancer
oncology
JNJ
Pfizer
Roche
Urogen
Are pharma’s DTC platforms actually creating engagement with patients?
Medical Marketing and Media
Tue, 05/6/25 - 10:27 am
DTC
patients
patient engagement
Eli Lilly
LillyDirect
Pfizer
PfizerForAll
Novo Nordisk
NovoCare
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
CNBC
Thu, 05/1/25 - 10:58 am
Pfizer
Pharma CEOs
Albert Bourla
drug manufacturing
tariffs
Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
Motley Fool
Wed, 04/30/25 - 11:00 am
Pfizer
obesity
PF-07976016
M&A
Viking Therapeutics
Altimmune
Pfizer’s Bourla ‘cautiously optimistic’ on looming US pharma tariffs
BioPharma Dive
Wed, 04/30/25 - 10:58 am
Pfizer
Albert Bourla
Pharma CEOs
tariffs
Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall
CNBC
Tue, 04/29/25 - 08:20 am
Pfizer
earnings
Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial
Clinical Trials Arena
Mon, 04/28/25 - 09:39 am
Pfizer
clinical trials
sasanlimab
BGC
non-muscle invasive bladder cancer
How a scrapped Pfizer drug became a winner for SpringWorks
Pharma Voice
Mon, 04/21/25 - 10:00 am
SpringWorks Therapeutics
Pfizer
neurofibromatosis
mirdametinib
FDA
CDC panel backs broader use of RSV shots
BioPharma Dive
Thu, 04/17/25 - 11:25 am
CDC
ACIP
vaccines
RSV
GSK
Pfizer
Moderna Therapeutics

Pages